Completed PHASE4 INTERVENTIONAL 2-arm NCT00731601

Intravenous Proton Pump Inhibitor for Peptic Ulcer Bleeding (PPI)

Phase 4 Study of Intravenous Proton Pump Inhibitor in Patients With Peptic Ulcer Bleeding After Successful Endoscopic Therapy- a Prospective Randomized Comparative Trial

Sponsor: Lotung Poh-Ai Hospital

Conditions Peptic Ulcer Hemorrhage

Interventions pantoprazole

Updated 5 times since 2017 Last updated: Apr 6, 2009 Started: May 31, 2008 Primary completion: Mar 31, 2009 Completion: Apr 30, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Peptic Ulcer Hemorrhage and is currently completed. Lotung Poh-Ai Hospital leads this study, which shows 5 recorded versions since 2008 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Jun 2018 — Jan 2021 [monthly]

Completed PHASE4
Jan 2017 — Jun 2018 [monthly]

Completed PHASE4

First recorded

May 2008

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Lotung Poh-Ai Hospital

Data source: Lotung Poh-Ai Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Yilan, Taiwan